Log in to search using one of your social media accounts:

 

US supercomputer Titan does calculations for HZDR cancer research

(Helmholtz-Zentrum Dresden-Rossendorf) For their calculations, researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will now, starting in 2015, have access to the World's second-fastest computer. The Dresden research initiative is one of 56 projects the US Department of Energy has granted access to Titan as part of their INCITE program. HZDR's 3-D simulations of laser-accelerated ions is listed as one of their six 2015 highlights. Insights from the computations may prove useful in proton-based cancer therapy.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news

Related Links:

  Purdue University is reporting on a new method of targeting cancer cells, developed by scientists in its Nuclear Engineering department. Dubbed PLASMAT, the technique combines cold atmospheric plasma, an ionized gas that brings with it active ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Surgery Source Type: blogs
Authors: Li Q, Wu J, Chen S, Zhao Y Abstract The introduction of the theory of cancer stem cells (CSCs) has provided a new direction and perspective for our understanding of the nature and origin of tumors. Cancer stem cells are believed to be responsible for the treatment failure, drug tolerance, metastasis, and recurrence of tumors. However, it remains a challenge to identify or isolate tumor stem cells and determine their regulatory mechanisms. Therefore, further understanding of the biological characteristics and functions of CSCs is of great practical significance and value to develop new methods of tumor diag...
Source: Histology and Histopathology - Category: Cytology Tags: Histol Histopathol Source Type: research
Preclinical tumor models are the foundation of translational cancer research. For exploring fundamental biologic mechanisms or designing new cancer therapies, in  vitro and in vivo models are the indispensable test environments in which countless discoveries have been made. Conventional models rely on immortalized cell lines that are notable for their reproducibility, convenience, and ease of use. Although these approaches continue to be widely used, their limitations are well known. In particular, these models are often criticized as poor reproductions of clinical tumors.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Research in Translation Source Type: research
AbstractHyperthermia is a promising alternative modality for the conventional cancer treatments. Nanoparticle-mediated photothermal therapy (PTT) has been widely applied for hyperthermia cancer therapy by a near-infrared light irradiation. Some special nanoparticles can convert light energy into heat and destroy the tumor cells. Inspired from the photothermal efficacy of the gold nanoparticles, here we synthesized, characterized, and applied novel photothermal polyethylene glycol-curcumin-gold nanoparticles (PEG-Cur-Au NPs) in cancer PTT. The effect of PEG-Cur-Au NPs upon irradiation by an 808-nm laser on C540 (B16/F10) ce...
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research
Senolytic compounds are those capable of selectively destroying senescent cells. They are useful because the buildup of senescent cells over time is one of the root causes of aging. A number of mechanisms have been discovered by which senescent cells can be provoked into self-destruction, such as bcl-2 inhibition or interference in FOXO4-p53 interactions. These examples are fairly well understood. Other mechanisms are known but less well understood; they require more work in order to proceed on the production of improved senolytic compounds. In some cases, however, the primary mechanism of action of a compound found...
Source: Fight Aging! - Category: Research Authors: Tags: Daily News Source Type: blogs
Publication date: Available online 20 May 2018 Source:The Journal of Steroid Biochemistry and Molecular Biology Author(s): Cristina Amaral, Tiago Vieira Augusto, Elisiário Tavares-da-Silva, Fernanda M.F. Roleira, Georgina Correia-da-Silva, Natércia Teixeira The leading cause of cancer death in women around the world is breast cancer. The aromatase inhibitors (AIs) are considered a first-line treatment for estrogen receptor-positive (ER+) breast tumors, in postmenopausal women. Exemestane (Exe) is a powerful steroidal AI, however, despite its therapeutic success, Exe-acquired resistance may occur leading to t...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
Publication date: 1 August 2018 Source:Life Sciences, Volume 206 Author(s): Qian Zhou, Chaoqun You, Cong Zheng, Yawen Gu, Hongchao Gu, Rui Zhang, Hongshuai Wu, Baiwang Sun DNA is considered to be one of the most promising targets for anticancer agents. Acridine analogues have anticancer activity based on DNA binding and topoisomerases inhibition. However, due to the side effects, resistance and low bioavailability, a few have entered into clinical usage and the mechanisms of action are not fully understood. Novel acridine derivatives are needed for effective cancer therapy. A series of novel 3-nitroacridine-based derivati...
Source: Life Sciences - Category: Biology Source Type: research
Publication date: 1 September 2018 Source:Colloids and Surfaces B: Biointerfaces, Volume 169 Author(s): Yiwen Li, Huailin Yang, Jiuxu Yao, Haiyang Yu, Xin Chen, Peng Zhang, Chunsheng Xiao An amphiphilic biodegradable prodrug (PLG-g-mPEG/CPT) was synthesized by conjugating disulfide-containing camptothecin (CPT) to poly(L-glutamic acid)-graft-methoxy poly(ethylene glycol) (PLG-g-mPEG) through esterification reaction. The amphiphilic prodrugs could self-assemble into micellar nanoparticles and encapsulate doxorubicin (DOX) in aqueous solution at pH 7.4. The treatment of the nanoparticles with reducing glutathione (GSH) at c...
Source: Colloids and Surfaces B: Biointerfaces - Category: Biochemistry Source Type: research
Authors: Aqbi HF, Tyutyunyk-Massey L, Keim RC, Butler SE, Thekkudan T, Joshi S, Smith TM, Bandyopadhyay D, Idowu MO, Bear HD, Payne KK, Gewirtz DA, Manjili MH Abstract Breast cancer patients who initially respond to cancer therapies often succumb to distant recurrence of the disease. It is not clear why people with the same type of breast cancer respond to treatments differently; some escape from dormancy and relapse earlier than others. In addition, some tumor clones respond to immunotherapy while others do not. We investigated how autophagy plays a role in accelerating or delaying recurrence of neu-overexpressing...
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
Publication date: 15 August 2018 Source:Journal of Molecular Liquids, Volume 264 Author(s): Chunhuan Shi, Zhiqing Zhang, Fang Wang, Yuxia Luan Active targeting agents can identify patients with receptors overexpressed on the surface of cancer cells. The selective and efficient drug delivery to tumor cells can remarkably improve different cancer therapeutic effect. Folic acid (FA) conjugation is a facile approach for targeting folate receptor-expressing tissues for personalized treatment. In the present study, ethoxy poly(ethylene glycol)- folic acid (FA-PEG) is introduced as the potent targeting moieties in docetaxel (DTX...
Source: Journal of Molecular Liquids - Category: Molecular Biology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Computers | Health | International Medicine & Public Health